Hudson Executive Capital LP Buys The Scotts Miracle Gro Co, USA Technologies Inc, Natera Inc, Sells Eagle Pharmaceuticals Inc, STORE Capital Corp, Corindus Vascular Robotics Inc

• New Purchases: SMG, NTRA,
• Added Positions: USAT,
• Reduced Positions: EGRX, STOR, CVRS, ATRC,

For the details of Hudson Executive Capital LP's stock buys and sells, go to https://www.gurufocus.com/guru/hudson+executive+capital+lp/current-portfolio/portfolio

1. Deutsche Bank AG (DB) - 64,861,476 shares, 48.17% of the total portfolio.
2. Cardtronics PLC (CATM) - 8,126,933 shares, 21.39% of the total portfolio.
3. SPDR S&P 500 ETF Trust (SPY) - 199,000 shares, 5.62% of the total portfolio.
4. USA Technologies Inc (USAT) - 7,195,720 shares, 5.15% of the total portfolio. Shares added by 144.02%
5. Eagle Pharmaceuticals Inc (EGRX) - 811,777 shares, 4.35% of the total portfolio. Shares reduced by 58.2%

Hudson Executive Capital LP initiated holding in The Scotts Miracle Gro Co. The purchase prices were between $79.68 and $98.5, with an estimated average price of $88.85. The stock is now traded at around $101.93. The impact to a portfolio due to this purchase was 3.42%. The holding were 360,275 shares as of .

Hudson Executive Capital LP initiated holding in Natera Inc. The purchase prices were between $17.75 and $27.58, with an estimated average price of $22.02. The stock is now traded at around $32.76. The impact to a portfolio due to this purchase was 1.01%. The holding were 378,589 shares as of .

Hudson Executive Capital LP added to a holding in USA Technologies Inc by 144.02%. The purchase prices were between $4.28 and $8.06, with an estimated average price of $6.19. The stock is now traded at around $8.13. The impact to a portfolio due to this purchase was 3.04%. The holding were 7,195,720 shares as of .

Hudson Executive Capital LP reduced to a holding in Eagle Pharmaceuticals Inc by 58.2%. The sale prices were between $46.61 and $58.45, with an estimated average price of $52.12. The stock is now traded at around $57.60. The impact to a portfolio due to this sale was -2.67%. Hudson Executive Capital LP still held 811,777 shares as of .

Hudson Executive Capital LP reduced to a holding in STORE Capital Corp by 50%. The sale prices were between $31.55 and $35.46, with an estimated average price of $33.75. The stock is now traded at around $36.07. The impact to a portfolio due to this sale was -1.4%. Hudson Executive Capital LP still held 890,800 shares as of .

Hudson Executive Capital LP reduced to a holding in Corindus Vascular Robotics Inc by 50%. The sale prices were between $1.8 and $3.21, with an estimated average price of $2.5. The stock is now traded at around $4.26. The impact to a portfolio due to this sale was -1.16%. Hudson Executive Capital LP still held 14,235,545 shares as of .

Hudson Executive Capital LP reduced to a holding in AtriCure Inc by 79.05%. The sale prices were between $26.85 and $30.74, with an estimated average price of $29.17. The stock is now traded at around $25.51. The impact to a portfolio due to this sale was -0.89%. Hudson Executive Capital LP still held 187,678 shares as of .